| I Suggest |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Food and Drink > Food and Drink > Whatever Happened to Genetically Modified Food? |
|
I Suggest - Whatever Happened to Genetically Modified Food?
Have you ever wondered what happened to genetically modified (GM) food? Does any of our food actually come from GM organisms, and does GM food have a future on the supermarket s According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product helves? Growing genetically modified crops which are hardier, pest-resistant or produce fruit with a longer shelf life was once thought to be the future of farming. However, th ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in British public did not embrace the idea of eating GM food, and now it is hard to find GM food on the shelves, and no GM crops are grown commercially in the UK. The first GM pr lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. duct seen in the UK was tomato puree, produced from GM tomatoes, which was introduced by Sainsbury's and Safeway in 1996. The puree was clearly labelled as coming from GM tomato here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe s, and this fact was well-publicised by the supermarkets. The puree was extremely popular, being slightly cheaper and having a better texture than its non-GM equivalent. So why d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro has GM tomato puree now vanished from the supermarkets? The British public turned against GM food in a big way, and this was probably triggered by a story in 1999 about rats suf ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc ering ill effects after eating GM potatoes. Although the study was extremely controversial and described as 'flawed' and 'misleading', it was scary enough to give anti-GM campai easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi ners the upper hand. You may find genetically modified products in processed food The first GM crops to be grown on a large scale were herbicide-resistant soya and pest-resist nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically nt maize. Growth of these crops is widespread in many countries including the USA. Most processed foods contain products derived from soya or maize, and these foods were immedi and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ tely labelled GM if there was a chance they contained anything derived from GM crops. However, this meant that customers rarely had the option to buy non-GM, and British food pr ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi ducers very quickly started to source from certified non-GM crops. The European Union has not approved the sale of any fresh GM produce - the only GM foods you are likely to se ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a e in Europe are imported, processed foods. GM food is much more widespread in the USA and does not have to be labelled as GM. The justification there is that GM products used in dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod food have been determined to be safe, and not substantially different from non-GM versions, therefore the mode of production is irrelevant. In the EU, food must be clearly labe cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin led if it 'intentionally' contains products from GM crops at any level. Food which 'accidentally' or 'unavoidably' contains GM-derived products at less than 1% does not need to tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen e labelled. A lot of animal feed contains GM soya or maize-derived products, but animal products (meat, eggs etc) from animals fed on GM food do not need to labelled. Food prod t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel ced using 'GM technologies' does not need to labelled either. A good example of this is the enzyme chymosin. Chymosin is the active ingredient of rennet, normally extracted from ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust the stomach lining of calves, and used in the production of many cheeses. Most cheeses are now made using chymosin isolated from genetically modified microorganisms, as this is y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products heaper and vegetarian-friendly. GM crops in the UK Growing GM crops has not been banned in the UK, but is unlikely to occur for commercial purposes before 2009, if at all. GM . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de rop trials are being tentatively re-introduced in the UK. In December 2006, permission was granted for a trial of blight elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:The Faster And Smarter Way To Connect To The Web: Broadband Services An Organized Closet is a Happy Closet
|